ReviewJournal of pregnancy2026
Late Onset Gestational Diabetes Mellitus: Clinical Implications of Delayed Diagnosis and a Pragmatic Approach to Screening: A Narrative Review.
Review in Journal of pregnancy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGestational diabetes mellitus (GDM) increases maternal and neonatal risks and its reported prevalence has risen with evolving diagnostic criteria and screening strategies. Although screening at 24-28 weeks is widely recommended, optimal testing methods and the value of screening outside that window remain contested. The aim of this narrative review is to critically examine the clinical significance, epidemiology, and pragmatic screening strategies for GDM first identified or retested in late pregnancy (the third trimester) after normal midpregnancy screening.
methodsThis narrative synthesis integrates findings from observational studies, retrospective cohorts, guideline statements, and relevant systematic reviews (including a 2024 meta-analysis) to summarize current knowledge and highlight gaps.
resultsReports show that repeat testing can detect new GDM cases. For example, one published retrospective cohort reported an 18.3% incidence among high-risk women retested in the third trimester. Observational evidence and published reviews indicate associations between late-diagnosed GDM and higher rates of shoulder dystocia, cesarean delivery, and low 5-min Apgar scores, though findings for macrosomia, neonatal hypoglycemia, and NICU admission are inconsistent. The short interval between late diagnosis and delivery limits the potential impact of interventions, and diagnosis itself may increase medicalization. Standard IADPSG OGTT thresholds were derived from 24-32-week cohorts and their applicability in later gestation is uncertain. Pragmatic, selective strategies-targeted retesting based on ultrasound or clinical risk, or screening with random glucose/HbA1c to detect overt hyperglycemia-may reduce unnecessary OGTTs while identifying clinically meaningful cases.
conclusionsAs a narrative review, this article synthesizes current evidence to conclude that late-onset GDM is clinically relevant but understudied; universal third-trimester OGTT is not yet supported by robust outcome data. Prospective studies are needed to define optimal screening populations, diagnostic criteria, and management in late pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.